The open access journal SynBio [1] was launched in 2023. This journal establishes a distinctive, multidisciplinary platform that synthesizes the rapidly evolving methodological and conceptual innovations in synthetic biology. SynBio seeks to comprehensively integrate these advances to support the development of novel industrial and medical applications.
Currently, SynBio is covered by 15 bibliographic databases and archives (https://www.mdpi.com/journal/synbio/indexing, accessed on 10 November 2025). As the journal prepares for inclusion in other major bibliographic databases, it is imperative to update and reiterate our original objectives and scope. The aim of this editorial is to outline the journal’s revised definition, aims, scope and requirements (https://www.mdpi.com/journal/synbio/about). Notably, the essence of these elements, first defined in 2023, remains unchanged.
SynBio (ISSN 2674-0583) is an international, peer-reviewed, open access journal published quarterly by MDPI. It disseminates comprehensive reviews, original scientific research articles, communications, case reports, commentaries and editorials on all aspects of synthetic biology. Submissions of theoretical and experimental articles are welcome.
Synthetic biology inherently draws upon and unifies diverse disciplines—including molecular biology, biochemistry, metabolism, and omics-driven systems biology—to design and engineer biological systems. These systems are applied to a wide range of purposes, such as biosensing, pollutant degradation, and the production of small molecules, biopolymers, and supramolecular structures. Solely focusing on traditional bioinformatics, molecular biology, or genetic engineering does not constitute synthetic biology, unless these tools are employed in the design or engineering of biological systems.
Progress in this domain is advancing rapidly, driven by breakthroughs in AI-assisted design concepts combined with advances in high-throughput DNA/RNA sequencing and DNA assembly technologies. These innovations are unveiling the full potential of biological systems in addressing globally pressing challenges in health, sustainability, and human well-being.
Synthetic biology is now entering a transformative phase, with increasing translation into tangible products and technologies. By 2030, it is expected to play a significant role in everyday life, contributing to food production, medical therapies, materials science, and energy solutions.
With our editors, board members, and publisher, we invite you to submit your research to SynBio and become involved in a vibrant, interdisciplinary community. We hope you will consider SynBio as your preferred journal for sharing impactful research, and we look forward to working with you to make this journal an essential resource for the synthetic biology field.
Conflicts of Interest
The author declares no conflicts of interest.
Reference
- SynBio Home Page. Available online: https://www.mdpi.com/journal/synbio (accessed on 13 October 2021).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.